Literature DB >> 20069541

The natural history of fibroids.

D Mavrelos1, J Ben-Nagi, T Holland, W Hoo, J Naftalin, D Jurkovic.   

Abstract

OBJECTIVES: Fibroids are common, hormone-dependent, benign uterine tumors. They can cause significant morbidity and the symptoms depend largely on their size. The aim of this study was to describe the natural history of fibroids and identify factors that may influence their growth.
METHODS: This was a retrospective longitudinal study of premenopausal women who were diagnosed with uterine fibroids on ultrasound examination. All women underwent at least two transvaginal ultrasound scans, which were all performed by a single operator. Fibroids were measured in three perpendicular planes and the mean diameter was calculated. The size and position of every individual fibroid was assessed and recorded on a computerized database. The volume of each fibroid was calculated using the formula for a sphere.
RESULTS: A total of 122 women were included in the study. Their median age at the initial examination was 40 (range, 27-45) years. Seventy-two (59.0%) were nulliparous and 74 (60.7%) had multiple fibroids. The median interval between the initial and final examination was 21.5 (range, 8-90) months. The median fibroid volume increased by 35.2% per year. Small fibroids (< 20 mm mean diameter) grew significantly faster than larger fibroids (P = 0.007). The median increase in size was significantly higher in cases of intramural fibroids (53.2 (interquartile range (IQR), 11.2-217)%) than in subserous fibroids (25.1 (IQR, 1.1-87.1)%) and submucous fibroids (22.8 (IQR, - 11.7 to 48.3)%) (P = 0.012). Multivariate analysis retained only fibroid size at presentation as an independent predictor of fibroid growth.
CONCLUSION: The growth of fibroids in premenopausal women is influenced by the tumor's size at presentation.

Entities:  

Mesh:

Year:  2010        PMID: 20069541     DOI: 10.1002/uog.7482

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  16 in total

1.  Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.

Authors:  Sergio A Machado; Janice M Bahr; D Buck Hales; Andrea G Braundmeier; Bradley J Quade; Romana A Nowak
Journal:  Biol Reprod       Date:  2012-10-11       Impact factor: 4.285

2.  Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.

Authors:  Donna D Baird; Stacy A Patchel; Tina M Saldana; David M Umbach; Tracy Cooper; Ganesa Wegienka; Quaker E Harmon
Journal:  Am J Obstet Gynecol       Date:  2020-02-24       Impact factor: 8.661

Review 3.  Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.

Authors:  Klaudia Żak; Bartłomiej Zaremba; Alicja Rajtak; Jan Kotarski; Frédéric Amant; Marcin Bobiński
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

4.  Natural Size Development of Myomata - Ultrasound Observational Study of 55 Premenopausal Patients.

Authors:  M David; L Adams; J H Stupin
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-01-21       Impact factor: 2.915

5.  A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.

Authors:  D D Baird; T M Saldana; D L Shore; M C Hill; J M Schectman
Journal:  Hum Reprod       Date:  2015-09-25       Impact factor: 6.918

Review 6.  Uterine fibroids in menopause and perimenopause.

Authors:  Mara Ulin; Mohamed Ali; Zunir Tayyeb Chaudhry; Ayman Al-Hendy; Qiwei Yang
Journal:  Menopause       Date:  2020-02       Impact factor: 2.953

7.  A Split-and-Merge-Based Uterine Fibroid Ultrasound Image Segmentation Method in HIFU Therapy.

Authors:  Menglong Xu; Dong Zhang; Yan Yang; Yu Liu; Zhiyong Yuan; Qianqing Qin
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

8.  Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study.

Authors:  Eman Roshdy; Veera Rajaratnam; Sarbani Maitra; Mohamed Sabry; Abdou S Ait Allah; Ayman Al-Hendy
Journal:  Int J Womens Health       Date:  2013-08-07

9.  Effect of Isopropanolic Cimicifuga racemosa Extract on Uterine Fibroids in Comparison with Tibolone among Patients of a Recent Randomized, Double Blind, Parallel-Controlled Study in Chinese Women with Menopausal Symptoms.

Authors:  Sisi Xi; Eckehard Liske; Shuyu Wang; Jianli Liu; Zhonglan Zhang; Li Geng; Lina Hu; Chunfeng Jiao; Shurong Zheng; Hans-Heinrich Henneicke-von Zepelin; Wenpei Bai
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-02       Impact factor: 2.629

10.  Urinary concentrations of phenols, parabens, and triclocarban in relation to uterine leiomyomata incidence and growth.

Authors:  Amelia K Wesselink; Jennifer Weuve; Victoria Fruh; Traci N Bethea; Birgit Claus Henn; Quaker E Harmon; Russ Hauser; Paige L Williams; Antonia M Calafat; Michael McClean; Donna D Baird; Lauren A Wise
Journal:  Fertil Steril       Date:  2021-08-05       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.